2024 University Hospitals Medicare Advantage Plan by PTHP
-
lake 7377942 1920
Read more about "lake 7377942 1920"... -
12.1.2024 Comprehensive for Website UHMAP
Read more about "12.1.2024 Comprehensive for Website UHMAP"... -
Provider Appeals
Payment Appeal – A challenge or an ‘appeal’ related to benefit/payment denials by the Medicare health plan that results in zero payment being made to the non-contracted Medicare health plan provider. Examples include: Benefit Determinations Medical necessity issues Coverage issues related to nation and/or local coverage determination policies Claims Payment Dispute – Any decision…
Read more about "Provider Appeals"... -
learn
Are you ready to learn more about Medicare? PrimeTime Health Plan offers Medicare Education webinars you can attend from the comfort of your home! Live Webinars: Select a date and time from the list below to attend a live webinar from your home. Once registered, you will receive an email with detailed information…
Read more about "learn"... -
10.1.2024 ST Criteria for Website PTHP
Read more about "10.1.2024 ST Criteria for Website PTHP"... -
Interoperability
Currently available to PrimeTime Health Plan Medicare Advantage Members and AultCare Marketplace Members. You may find a mobile app or computer program that requests access to your health information to help you monitor your personal health goals. As your health plan, we need to provide a way for you to…
Read more about "Interoperability"... -
12.1.2024 ST Criteria for Website PTHP
Read more about "12.1.2024 ST Criteria for Website PTHP"... -
National Resources
Read more about "National Resources"... -
H3664 M3P ParticipationRequest C
Read more about "H3664 M3P ParticipationRequest C"... -
2024 Formularies
PrimeTime Health Plan formulary covers both brand name drugs and generic drugs. Generic drugs have the same active-ingredient formula as a brand name drug. Generic drugs usually cost less than brand name drugs and are rated by the Food and Drug Administration (FDA) to be as safe and effective as…
Read more about "2024 Formularies"...